AbilTo completes Series A financing to expand proprietary programs and technology platform

AbilTo, Inc., a company that delivers proven behavioral health programs to help adults overcome mild and moderate depression associated with major medical events, announced today the completion of a $3 million round of Series A financing to fund the expansion of the Company's proprietary programs and technology platform. The financing round was led by .406 Ventures. AbilTo works through health plans and employers to provide remotely delivered behavioral health programs via phone or secure video link. Current offerings address depression associated with cardiac events, diabetes, chronic pain, breast cancer diagnosis and childbirth.

“We are very excited to be partnering with AbilTo. The company's combination of great outcomes for patients and meaningful savings for health plans and employers is the magic combination that we seek when investing in healthcare technology companies.”

"We are very excited to be partnering with AbilTo. The company's combination of great outcomes for patients and meaningful savings for health plans and employers is the magic combination that we seek when investing in healthcare technology companies." said Liam Donohue, Co-Founder and General Partner of .406 Ventures.

Each AbilTo program is tailored to the unique challenges caused by a particular medical event and helps a patient learn new skills that positively impact mental and medical health over the course of eight-weeks. In 2011, AbilTo began collaborating with Aetna, starting with the Cardiac Health Forum to improve patient outcomes after major heart-related events.

"In the two years since we implemented AbilTo's approach, participating Aetna members have experienced, on average, a 70-80% reduction in depression. Today, we offer six AbilTo programs and are pleased that so many of our plan sponsors are choosing to offer them to their employees," said William Gillis, Psy.D., Head of Behavioral Health Program Design and Product Support, Aetna.

"With the support of .406 Ventures, we are well positioned to expand our provider network, enhance our platform capabilities and increase our program offerings, allowing us to reach additional populations who can benefit from AbilTo's unique approach" said Michael Laskoff, CEO, AbilTo.

SOURCE AbilTo, Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics